These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 2154802)

  • 1. Opioid involvement in epileptogenic and neurovisceral activity.
    Pinsky C; Bose R; Hall A; Glavin GB
    Prog Clin Biol Res; 1990; 328():421-4. PubMed ID: 2154802
    [No Abstract]   [Full Text] [Related]  

  • 2. Functional response of multiple opioid systems to chronic arthritic pain in the rat.
    Millan MJ; Millan MH; Członkowski A; Pilcher CW; Höllt V; Colpaert FC; Herz A
    Ann N Y Acad Sci; 1986; 467():182-93. PubMed ID: 2873784
    [No Abstract]   [Full Text] [Related]  

  • 3. Dynorphin prolongs the action potential duration of mouse sensory ganglion neurons by decreasing a K+ conductance whereas the specific kappa opioid, U-50,488H does so by increasing a Ca2+ conductance.
    Shen KF; Crain SM
    Prog Clin Biol Res; 1990; 328():343-6. PubMed ID: 1968268
    [No Abstract]   [Full Text] [Related]  

  • 4. Action at the mu receptor is sufficient to explain the supraspinal analgesic effect of opiates.
    Fang FG; Fields HL; Lee NM
    J Pharmacol Exp Ther; 1986 Sep; 238(3):1039-44. PubMed ID: 3018217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New approaches to the evaluation of opioid agonists and antagonists upon the isolated, electrically stimulated mouse vas deferens preparation.
    Smith CB
    NIDA Res Monogr; 1987; 76():288-94. PubMed ID: 2830524
    [No Abstract]   [Full Text] [Related]  

  • 6. Kappa-opioid agonists do not inhibit adenylate cyclase.
    Makimura M; Murakoshi Y
    J Pharmacobiodyn; 1989 Mar; 12(3):125-31. PubMed ID: 2547926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kappa opioid partial agonist activity of the enkephalin-like pentapeptide BW942C based on urination and in vitro studies in humans and animals.
    Vaupel DB; Cone EJ; Johnson RE; Su TP
    J Pharmacol Exp Ther; 1990 Jan; 252(1):225-34. PubMed ID: 2153801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of cannabinoid-induced antinociception by norbinaltorphimine, but not N,N-diallyl-tyrosine-Aib-phenylalanine-leucine, ICI 174,864 or naloxone in mice.
    Welch SP
    J Pharmacol Exp Ther; 1993 May; 265(2):633-40. PubMed ID: 8388455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effect of mu, delta, and kappa opioid agonists on adenylate cyclase activity.
    De Montis GM; Devoto P; Preti A; Tagliamonte A
    J Neurosci Res; 1987; 17(4):435-9. PubMed ID: 2887665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid receptor agonists and Ca2+ modulation in human B cell lines.
    Heagy W; Shipp MA; Finberg RW
    J Immunol; 1992 Dec; 149(12):4074-81. PubMed ID: 1334111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of exocrine pancreatic secretion by opiates is mediated by suppression of cholinergic transmission: characterization of receptor subtypes.
    Louie DS; Chen HT; Owyang C
    J Pharmacol Exp Ther; 1988 Jul; 246(1):132-6. PubMed ID: 2455787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Similar actions of kappa and mu agonists on spinal nociceptive reflexes in rats and their reversibility by naloxone.
    Parsons CG; West DC; Headley PM
    NIDA Res Monogr; 1986; 75():461-4. PubMed ID: 2828992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mu- and delta-opioid modulation of electrically-induced epileptic seizures in mice.
    Pinsky C; Bose R; Frederickson RC
    NIDA Res Monogr; 1986; 75():543-6. PubMed ID: 2829000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indirect involvement of delta opioid receptors in cholecystokinin octapeptide-induced analgesia in mice.
    Hong EK; Takemori AE
    J Pharmacol Exp Ther; 1989 Nov; 251(2):594-8. PubMed ID: 2553928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional differences in opioid receptor-mediated inhibition of dopamine and acetylcholine release in the rat brain.
    Heijna MH; Schoffelmeer AN; Mulder AH
    Prog Clin Biol Res; 1990; 328():299-302. PubMed ID: 2154785
    [No Abstract]   [Full Text] [Related]  

  • 16. Influence of opioids on CSF vasopressin concentration in newborn pigs.
    Armstead WM; Crofton JT; Share L; Mirro R; Zuckerman SL; Leffler CW
    Am J Physiol; 1992 Mar; 262(3 Pt 2):H862-7. PubMed ID: 1348399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different motor actions of dynorphins and nonpeptide kappa opioid receptor agonists in the isolated rat colon.
    Scheurer U; Wenger F; Caliezi A; Drack E; Varga L; Halter F
    J Pharmacol Exp Ther; 1990 Mar; 252(3):1324-30. PubMed ID: 1969475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynorphin prolongs the action potential of mouse sensory ganglion neurons by decreasing a potassium conductance whereas another specific kappa opioid does so by increasing a calcium conductance.
    Shen KF; Crain SM
    Neuropharmacology; 1990 Apr; 29(4):343-9. PubMed ID: 1971431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inhibitory effects of dynorphin on electric field stimulation induced contraction of blood vessels in vitro].
    Sun FY; Zhang AZ; Zhang LM; Yu GH
    Zhongguo Yao Li Xue Bao; 1984 Dec; 5(4):245-8. PubMed ID: 6152647
    [No Abstract]   [Full Text] [Related]  

  • 20. Antidiarrheal properties of supraspinal mu and delta and peripheral mu, delta and kappa opioid receptors: inhibition of diarrhea without constipation.
    Shook JE; Lemcke PK; Gehrig CA; Hruby VJ; Burks TF
    J Pharmacol Exp Ther; 1989 Apr; 249(1):83-90. PubMed ID: 2540324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.